Associate Professor
Lovelace Biomedical
Denis E Bragin, Ph.D., FAHA, Associate Professor of Translational Neuroscience, Lovelace Biomedical Research Institute; Associate Professor, Department of Neurology, University of New Mexico Health Sciences Center School of Medicine. Dr. Bragin is a Fellow of the American Heart Association (Stroke Council) and a member of the American Heart Association, the International Society for Cerebral Blood Flow and Metabolism, the International Society on Oxygen Transport to Tissue, the Society of Photo-Optical Instrumentation Engineers, and the Society of Critical Care Medicine. He has contributed to over 60 scientific publications in peer-reviewed journals, contributed to over 100 presentations at national and international meetings, and received 5 US and Russian patents. Dr. Bragin has been successfully funded by the National Institute of Health, the Department of Defense, and the American Heart Association. Currently, he is the PI on NIH RO1 studying hemorheologic modulation of cerebral blood flow for the treatment of traumatic brain injury.
His research focuses on the circulation and metabolism of the brain after traumatic brain injury, stroke, and other cerebrovascular and metabolic diseases of the brain. His current research interests include:
· The role of cerebral microvascular shunting in the development of hyperemia, brain edema, tissue ischemia, and blood-brain barrier degradation during intracranial hypertension after severe cerebral insults.
· The potential of hemodynamics modulation with drag-reducing molecules for treating acute and chronic cerebral microvascular disorders and ischemia, including stroke, traumatic injury, diabetic encephalopathy, and other neurodegenerative diseases.
· Non-invasive transcranial direct current, pulsed electromagnetic field, and low-level light brain modulation for recovery after acute brain injuries.